Macro Strategist, Saxo Capital Markets

Kay Van-Petersen

Macro Strategist

Saxo Capital Markets

Thematic (Sector/Industry)

<ul><li>With CHF last at 0.9033, we are +5% (unlevered) on the cross since the Fri Jan 16th call where it closed at 0.8587. I continue to believe and feel this is a big trade for the year, I am a lot more relaxed now that we are on the other side of the ECB and Greek election and think we are north of 1.02-1.05 in the 2nd half of the year </li><li>The size of ECB QE is not priced in – There is massive European Equities Upside!&nbsp;The case here is simple, we’ve just come out of a greater than anticipated QE from the ECB, that is open ended and set to run until Sep 2016.&nbsp;Whilst the market was more likely thinking we’d get a Euros 500-700bn handle, we got over a trillion euros worth, with a lot fewer parameters or caps than would have been expected by those pesky conservative Bundesbankers – who keep wanting to turn off the taps (I know I know, how dare they). </li></ul>

With CHF last at 0.9033, we are +5% (unlevered) on the cross since the Fri Jan 16th call where it closed at 0.8587. I continue to believe and feel this is a big trade for the year, I am a lot more relaxed now that we are on the other side of the ECB and Greek election and think we are north of 1.02-1.05 in the 2nd half of the year The size of ECB QE is not priced in – There is massive European Equities Upside!&nbsp;The case here is simple, we’ve just come out of a greater than anticipated QE from the ECB, that is open ended and set to run until Sep 2016.&nbsp;Whilst the market was more likely thinking we’d get a Euros 500-700bn handle, we got over a trillion euros worth, with a lot fewer parameters or caps than would have been expected by those pesky conservative Bundesbankers – who keep wanting to turn off the taps (I know I know, how dare they). 

The size of ECB QE is not priced in – Massive European Equities Upside

Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>Unum Group's second quarter of 2025 showcased a mixed performance, with both strengths and areas of concern impacting their financial outcomes.</li><li>From an operational standpoint, Unum experienced premium growth of nearly 5%, with this growth seen across most product lines.</li><li>The increase in premiums can be attributed to successful renewals, an upswing in the number of employees on payroll, and new customer additions.</li></ul>

Unum Group's second quarter of 2025 showcased a mixed performance, with both strengths and areas of concern impacting their financial outcomes.From an operational standpoint, Unum experienced premium growth of nearly 5%, with this growth seen across most product lines.The increase in premiums can be attributed to successful renewals, an upswing in the number of employees on payroll, and new customer additions.

Unum Group Strengthens Long-Term Care Business with 60% Premium Adjustments Secured!

<ul><li>Unum Group's first quarter results for 2025 demonstrate a blend of strengths and challenges that are vital for investors to consider.</li><li>The company reported a return on equity (ROE) for core operations exceeding 20%, alongside premium growth of more than 4%.</li><li>However, despite these positive indicators, Unum's earnings per share of $2.04 fell short of expectations, primarily due to an increase in disability claims.</li></ul>

Unum Group's first quarter results for 2025 demonstrate a blend of strengths and challenges that are vital for investors to consider.The company reported a return on equity (ROE) for core operations exceeding 20%, alongside premium growth of more than 4%.However, despite these positive indicators, Unum's earnings per share of $2.04 fell short of expectations, primarily due to an increase in disability claims.

Unum Group Surges Internationally with Double-Digit Growth in Poland and the U.K.; What Lies Ahead?

<ul><li>Unum Group's recent financial performance suggests a robust position in its market, marked by strong earnings, solid capital management, and strategic initiatives aimed at growth.</li><li>In 2024, the company posted a 10% increase in earnings per share, surpassing initial projections.</li><li>A major driver was Unum’s core operations delivering a return on equity (ROE) of over 20%.</li></ul>

Unum Group's recent financial performance suggests a robust position in its market, marked by strong earnings, solid capital management, and strategic initiatives aimed at growth.In 2024, the company posted a 10% increase in earnings per share, surpassing initial projections.A major driver was Unum’s core operations delivering a return on equity (ROE) of over 20%.

Unum Group: Growth in Core & Large Case Markets Signaling Brilliant Future Growth & Amplified Market Penetration!

<ul><li>Unum Group has reported its third-quarter 2024 financial performance, accentuating a strong overall operational landscape with both prospects and challenges.</li><li>On the positive side, adjusted earnings per share (EPS) were reported at $2.13, contributing to over $1 billion in statutory earnings year-to-date.</li><li>This performance aligns with Unum Group’s objective of achieving EPS growth of 10% to 15% for the full year, surpassing initial estimates.</li></ul>

Unum Group has reported its third-quarter 2024 financial performance, accentuating a strong overall operational landscape with both prospects and challenges.On the positive side, adjusted earnings per share (EPS) were reported at $2.13, contributing to over $1 billion in statutory earnings year-to-date.This performance aligns with Unum Group’s objective of achieving EPS growth of 10% to 15% for the full year, surpassing initial estimates.

United States

Unum Group provides group disability and special risk insurance.  The Company provides disability insurance, group life insurance, and payroll-deducted voluntary benefits offered to employees at their worksites.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Unum Group (UNM US)

The size of ECB QE is not priced in – Massive European Equities Upside

With CHF last at 0.9033, we are +5% (unlevered) on the cross since the Fri Jan 16th call where it closed at 0.8587. I continue to believe and...

Kay Van-Petersen

Unum Group Strengthens Long-Term Care Business with 60% Premium Adjustments Secured!

Unum Group's second quarter of 2025 showcased a mixed performance, with both strengths and areas of concern impacting their financial...

Baptista Research

Unum Group Surges Internationally with Double-Digit Growth in Poland and the U.K.; What Lies Ahead?

Unum Group's first quarter results for 2025 demonstrate a blend of strengths and challenges that are vital for investors to consider. The company...

Baptista Research

Unum Group: Growth in Core & Large Case Markets Signaling Brilliant Future Growth & Amplified Market Penetration!

Unum Group's recent financial performance suggests a robust position in its market, marked by strong earnings, solid capital management, and...

Baptista Research

Unum Group: Tackling Capital Allocation

Unum Group has reported its third-quarter 2024 financial performance, accentuating a strong overall operational landscape with both prospects and...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)